Key result
Autoimmunity against glycation-modified antigens emerges as a novel target for diabetic vascular complications.
PURPOSE OF REVIEW: Diabetes is associated with an increased risk for cardiovascular disease. The purpose of this review is to discuss possible mechanisms through which diabetes can contribute to a more aggressive atherosclerotic disease process with a particular focus on the role of innate and adaptive immunity. RECENT FINDINGS: The observation that adaptive immune responses to oxidized LDL modulate atherosclerotic plaque development has led to development of pilot vaccines that inhibit atherosclerosis in experimental animals. Recent studies have shown that similar immune responses operate against self-antigens modified by glycation in diabetes. Diabetes has also been shown to activate proinflammatory innate immune receptors and intracellular oxidative stress. SUMMARY: There are many similarities between the autoimmune responses against oxidized LDL and proteins modified by glycation. The role of autoimmune responses against modified self-antigens in the development of diabetic vascular complications represents a relatively unexplored concept that potentially could provide significant new mechanistic insight into the underlying disease process and identify novel targets for intervention.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (2008) conducted a review in Diabetic vascular complications. Autoimmune responses against modified self-antigens was evaluated. Autoimmune responses against glycation-modified self-antigens in diabetes represent an unexplored mechanism for vascular complications and a potential novel target for intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: